Bill Petron

PharmaCielo Ltd. (TSXV: PCLO) (OTCQX: PCLOF) the Canadian parent of Colombia's premier cultivator and producer of dried flower and medicinal-grade cannabis extracts, PharmaCielo Colombia Holdings S.A.S., today announced financial results for the first quarter ended March 31, 2023...

PharmaCielo Ltd. (OTCQX: PCLOF) (TSXV:PCLO) released financial results for the fourth quarter and year ended December 31, 2022, revealing total revenue of CA$5.3 million ($3.9 million), an increase of 173% compared to CA$1.9 million in FY 2021. FY 2022 Financial Highlights Gross profit of CA$827,...

PharmaCielo Ltd. (TSXV:PCLO) (OTCQX: PCLOF), released financial results for the third quarter ended September 30, 2022, revealing total revenue of CA$475,323 ($348,000), a 2% decrease compared to CA$485,165 in Q3 2021. Q3 Financial Highlights Gross profit was a loss of CA$305,850 compared to a...

PharmaCielo Ltd. (OTCQX: PCLOF) (TSXV:PCLO) has made its first shipment of THC-dominant dried cannabis flower to a customer in the Czech Republic, in the EU market. The customer is an established cannabinoid-focused pharmaceutical distributor and clinical research organization in the country. The...

PharmaCielo Ltd. (OTCQX: PCLOF) (TSXV:PCLO) Q2 2022 revenue was CA$2.1 million, a 375% increase compared to CA$446,000 in Q2 2021. Q2 2022 Financial Highlights Net loss was CA$3.5 million compared to net loss of CA$7.2 million in Q2 2021. Adjusted EBITDA was a loss of CA$2.1 million compared to...

The Benzinga Cannabis Capital Conference in Chicago, September 13-14, will celebrate the most recognized Latin American cannabis companies. This year's attendees will have the opportunity to meet the best Latin American brands in the industry that entered the emerging market and knew how to...

PharmaCielo Ltd. (OTCQX: PCLOF) (TSXV:PCLO) made its first shipment of cannabinoid products to its Mexican joint venture PharmaCielo S.A. de C.V. ("PharmaCielo Mexico"). The company's joint partner in PharmaCielo Mexico is MINO Labs S.A. de C.V., which is a specialty pharmaceutical...

As Benzinga Cannabis Capital Conference returns (September 13-14) to Chicago, gathering top CEOs, investors and leaders in the industry, let's scroll through the latest leadership changes within the space. PharmaCielo Announces New Appointments PharmaCielo Ltd. (TSXV: PCLO) (OTCQX: PCLOF), the...

PharmaCielo Ltd. (OTCQX: PCLOF) (TSXV:PCLO) the Canadian parent of Colombia's premier cultivator and producer of dried flower and medicinal-grade cannabis extracts, PharmaCielo Colombia Holdings S.A.S., shipped an initial shipment of a CBD full spectrum extract with THC content to a well-...

PharmaCielo Ltd. (OTCQX: PCLOF) (TSXV:PCLO) Q1 2022 revenue was CA$1.2 million ($947,000) compared to CA$675,000 in Q1 2021, an increase of 77.92%. Q1 Highlights Adjusted EBITDA was a loss of CA$1.57 million compared to a loss of CA$3.3 million in Q 2021 Net Loss was CA$2.91 million compared to...

PharmaCielo Ltd. (OTCQX: PCLOF) (TSXV:PCLO) , the Canadian parent of Colombia's premier cultivator and producer of dried flower and medicinal-grade cannabis extracts, PharmaCielo Colombia Holdings S.A.S. has made an initial shipment of CBD full spectrum oil containing THC to Extractions...

PharmaCielo Ltd. (OTCQX: PCLOF) (TSXV:PCLO) parent of PharmaCielo Colombia Holdings S.A.S, has signed an investment agreement with Soteria Holdings Limited. Under the terms of the agreement, Soteria's Polish operating subsidiary will apply for a number of licenses to import and wholesale the...

PharmaCielo Ltd. (OTCQX: PCLOF) (TSXV:PCLO), the Canadian parent of Colombia's premier cultivator and producer of dried flower and medicinal-grade cannabis extracts, PharmaCielo Colombia Holdings S.A.S., announced financial results for the fourth quarter and year ended December 31, 2021. 2021...

Colombian cannabis companies are now able to export THC and CBD-dried flower. The government's completion of a regulatory checklist will essentially enable such cannabis companies as Flora Growth (NASDAQ: FLGC) and PharmaCielo (TSXV: PCLO) (OTCQX:...

PharmaCielo (OTCQX: PCLOF) will start supplying the German market with three THC-dominant products, with commercial shipments expected to begin in late 2022. This is PharmaCielo's first sales agreement related to THC products. It represents a significant milestone related to management...